Astra-Idl Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
as on 17-11-2024
- Paid Up Capital ₹ 4.00 M
as on 17-11-2024
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.25 Cr
as on 17-11-2024
- Revenue 5769.40%
(FY 2023)
- Profit -398.11%
(FY 2023)
- Ebitda 1.97%
(FY 2023)
- Net Worth -18.82%
(FY 2023)
- Total Assets 112.88%
(FY 2023)
About Astra-Idl
The Corporate was formerly known as Zestra Life Sciences Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 4.00 M.
The company has closed loans amounting to ₹4.25 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Subhash Agrawal, Gulab Agrawal, and Sonam Agrawal serve as directors at the Company.
- CIN/LLPIN
U24239MH2006PLC161943
- Company No.
161943
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Jun 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Astra-Idl Limited offer?
Astra-Idl Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Pharmaceutical Syrup, Dry Syrups, Health Drinks, Junior Horlicks, Calcium Tablet, Calcium Citrate Malate Tablet, Herbal Capsules, Astaxanthin Capsules.
Who are the key members and board of directors at Astra-Idl?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subhash Agrawal  | Director | 22-Jun-2006 | Current |
| Gulab Agrawal | Director | 22-Jun-2006 | Current |
| Sonam Agrawal | Director | 22-Jun-2006 | Current |
Financial Performance and Corporate Structure Insights of Astra-Idl.
Astra-Idl Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 5769.4% increase. The company also saw a substantial fall in profitability, with a 398.11% decrease in profit. The company's net worth observed a substantial decline by a decrease of 18.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Astra-Idl?
In 2023, Astra-Idl had a promoter holding of 92.67% and a public holding of 7.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
P-Trade Fmcg Private LimitedActive 13 years 5 monthsSubhash Agrawal and Gulab Agrawal are mutual person
Pharma Traders Private LimitedActive 23 years 11 monthsSubhash Agrawal and Gulab Agrawal are mutual person
Devi Anusuiya Vidya SansthanActive 13 years 8 monthsSubhash Agrawal and Gulab Agrawal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Dec 2007 | ₹4.25 Cr | Satisfied |
How Many Employees Work at Astra-Idl?
Unlock and access historical data on people associated with Astra-Idl, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Astra-Idl, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Astra-Idl's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
